Rezolute

RZLTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$451.611 M

$4.69 -0.21%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$74.4M

Loss-making

Shares outstanding

96,292,331

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#215Prothena Corp PublicPRTA$458.6M
#216Puma BiotechnologyPBYI$453.5M
#217RezoluteRZLT$451.6M
#218Larimar TherapeuticsLRMR$432.2M
#219Assembly BiosciencesASMB$424.0M

Where these numbers come from

Share counts and financials for Rezolute are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.